- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3389/fphys.2019.00326
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2019
- Urheber
-
Drescher, Hannah K.
Brandt, Elisa F.
Fischer, Petra
Dreschers, Stephan
Schwendener, Reto A.
Kowalska, M. Anna
Canbay, Ali E.
Wasmuth, Hermann Elard
Weiskirchen, Ralf
Trautwein, Christian
Berres, Marie-Luise
Kroy, Daniela Christina
Sahin, Hacer
- DOI
-
10.18154/RWTH-CONV-238353
- URN
-
urn:nbn:de:101:1-2023040504523486880448
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Drescher, Hannah K.
- Brandt, Elisa F.
- Fischer, Petra
- Dreschers, Stephan
- Schwendener, Reto A.
- Kowalska, M. Anna
- Canbay, Ali E.
- Wasmuth, Hermann Elard
- Weiskirchen, Ralf
- Trautwein, Christian
- Berres, Marie-Luise
- Kroy, Daniela Christina
- Sahin, Hacer
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2019
Ähnliche Objekte (12)
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Cell therapy in liver fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Magnetic-assisted treatment of liver fibrosis
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Established liver cell lines: are you sure to have the right ones?
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Resveratrol: Is It Really Good for Liver Health?
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Cell therapy in liver fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Magnetic-assisted treatment of liver fibrosis
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Established liver cell lines: are you sure to have the right ones?
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Resveratrol: Is It Really Good for Liver Health?
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Cell therapy in liver fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Magnetic-assisted treatment of liver fibrosis
Autophagy in Parenchymal and Non-Parenchymal Liver Cells
Established liver cell lines: are you sure to have the right ones?
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Resveratrol: Is It Really Good for Liver Health?